Press release
The Mercury Within: Unmasking a Silent Killer Behind Alzheimer's
Author's Tranquility Press proudly announces the release of Evidence That Mercury Causes Alzheimer's Disease [https://www.amazon.com/Evidence-Mercury-Causes-Alzheimers-Disease/dp/195705400X/ref=tmm_pap_swatch_0?_encoding=UTF8&dib_tag=se&dib=eyJ2IjoiMSJ9.QQzY_ROfiHhR1xfbiYDQkA.J9a0kvSJ9Ig0uMXwRSNnGGVoUALntKGWogSc-x87RFM&qid=1752879297&sr=1-1] by Dr. Robert Siblerud, a book that is turning heads across medical, environmental, and wellness communities. With clinical clarity and courageous honesty, this groundbreaking work presents compelling evidence that mercury-particularly from dental amalgam-may be the long-overlooked trigger behind one of the most devastating neurological disorders of our time.
This isn't speculation. It's science with consequences.
The Hidden Metal in Our Mouths. The Degeneration in Our Minds. The Link No One Wanted to Believe.
For more than a century, Alzheimer's disease has been a riddle-its cause shrouded in mystery, its treatment elusive. But what if the key to unlocking this devastating disease has been hiding in plain sight... behind your smile?
In Evidence That Mercury Causes Alzheimer's Disease , Dr. Robert Siblerud builds an astonishing case that mercury-particularly from dental fillings-may be a critical, causal factor in Alzheimer's. Drawing on decades of research, he outlines 70 scientifically validated markers of Alzheimer's disease that all intersect with mercury toxicity.
This is not fringing theory-it's a meticulously documented call to action, backed by institutions like the World Health Organization, which has identified dental amalgam as the single greatest source of human mercury exposure.
A Call for Awareness, A Blueprint for Prevention
Inside these pages, readers will discover:
*
How mercury from dental fillings enters the bloodstream and is absorbed by the brain
*
The biological mechanisms by which mercury damages neural tissue and disrupts cognitive function
*
Why certain mental illnesses-from depression to schizophrenia-may also share this same toxic root
*
Stories of hope: how patients improved or even recovered after amalgam removal
*
Practical guidance on prevention, detoxification, and reclaiming brain health
If you or someone you love is worried about memory loss, mood disorders, or long-term neurological health, this book could change your future.
Now Available on Amazon
What if the cause of Alzheimer's has been staring us in the face-and sitting in our teeth? Read Evidence That Mercury Causes Alzheimer's Disease and discover the facts no one told you. This eye-opening book is available now in both print and eBook editions. It's an essential read for caregivers, medical professionals, health-conscious individuals-and anyone who refuses to accept Alzheimer's as an unsolvable mystery.
Get your hands on this must-read-available now on Amazon [https://www.amazon.com/Evidence-Mercury-Causes-Alzheimers-Disease/dp/195705400X/ref=tmm_pap_swatch_0?_encoding=UTF8&dib_tag=se&dib=eyJ2IjoiMSJ9.QQzY_ROfiHhR1xfbiYDQkA.J9a0kvSJ9Ig0uMXwRSNnGGVoUALntKGWogSc-x87RFM&qid=1752879297&sr=1-1]!
About the Author
Dr. Robert Siblerud is an environmental physiologist, nutritionist, and retired optometrist known for his clear-eyed research and strong dedication to uncovering the dangers of mercury exposure. He has published 20 scientific papers on the health effects of dental amalgam, with studies carried out at Colorado State University and the Rocky Mountain Research Institute. This book is the result of decades of work and a lifelong commitment to public health.
About Author's Tranquility Press
Author's Tranquility Press, based in Marietta, Georgia, is a literary launchpad for authors with powerful stories and transformative insights. Their mission is to elevate voices that make a difference-stories that disrupt, heal, and ignite change.
Learn more at www.authorstranquilitypress.com. [https://www.authorstranquilitypress.com/]
Media Contact
Company Name: Author's Tranquility Press
Contact Person: Louela Sanders - Marketing Fulfillment Associate
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=the-mercury-within-unmasking-a-silent-killer-behind-alzheimers]
Phone: (866) 411-8655
Address:531 Roselane Street NW Suite 400-175
City: Marietta
State: Georgia, 30060
Country: United States
Website: http://www.authorstranquilitypress.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Mercury Within: Unmasking a Silent Killer Behind Alzheimer's here
News-ID: 4144594 • Views: …
More Releases from ABNewswire
Complicated Urinary Tract Infection Market to Experience Notable Growth in Forec …
The Key Complicated Urinary Tract Infection Companies in the market include - Allecra Therapeutics, Merck Sharp & Dohme, AbbVie, Shionogi, Melinta Therapeutics, Spero Therapeutics, Wockhardt, Meiji, Venatorx Pharmaceuticals, Evopoint Pharmaceuticals, and others..
DelveInsight's "Complicated Urinary Tract Infection Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Complicated Urinary Tract Infection, historical and forecasted epidemiology as well as the Complicated Urinary Tract Infection market trends in the United…
Coronado Beach Production's Film "Starstruck" to Premiere at the Central Florida …
The short film will air publicly for the first time during the festival in Mt. Dora from January 23-25, 2026.
Orlando, Fla. - Jan 08, 2026 - Coronado Beach Productions [https://coronadobeachproductions.com/], an Orlando-based independent film company with 40 years of film production experience, has announced that its short film "Starstruck" will make its public debut later this month after being accepted into the 20th annual Central Florida Film Festival [https://cenflo.us/]. This…
KRAS Inhibitors Market Dynamics Indicate Upward Trajectory Through 2034, Reports …
The Key KRAS Inhibitors Companies in the market include - Pfizer, Roche/Chugai/Genentech, Revolution Medicines, Eli Lilly and Company, Merck, Taiho, and Astex Pharmaceuticals, Elicio Therapeutics, Jiangsu Hengrui Pharmaceuticals, Cardiff Oncology, Genfleet Therapeutics and Innovent, Jacobio Pharma, Tyligand Pharmaceuticals (Suzhou), Silexion Therapeutics and Catalent, Astellas Pharma, Incyte, Quanta Therapeutics, and others.
DelveInsight's "KRAS Inhibitors Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the KRAS Inhibitors, historical and forecasted…
The U.S. Drone Boom: How Policy and Market Growth Could Create Winners (ZENA, AV …
The commercial and defense drone market is entering a period of rapid growth. The global industry is projected to surpass $29 billion by 2026, with a ~15% CAGR, driven by applications in logistics, infrastructure inspection, public safety, and defense. Militaries are expanding unmanned systems for surveillance, logistics, and force protection, while commercial operators increasingly adopt drones through recurring service contracts for inspection, mapping, security, and monitoring.
Regulatory shifts are now a…
More Releases for Alzheimer
Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment …
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928
Key Takeaways
• Disease-modifying…
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
